Showing 1 - 10 of 379
Persistent link: https://www.econbiz.de/10001948621
We study the effects of a change in the way patient reimbursements are calculated on the prices of pharmaceuticals using quasi-experimental data for Denmark which switched from external (where reimbursements are based on prices of similar products in foreign countries) to internal reference...
Persistent link: https://www.econbiz.de/10010467805
This paper analyzes whether part-time employment is beneficial for firm productivity in the service sector. Using a unique dataset on the Dutch pharmacy sector that includes the work hours of all employees and a "hard" physical measure of firm productivity, we estimate a production function...
Persistent link: https://www.econbiz.de/10009124147
What makes prescription drugs cost so much? The media and Congress say it is corporate greed, while pharmaceutical firms blame federal regulations and an expensive drug development process. This study focuses on R & D (R&D) expenditures at global pharmaceutical firms and explores the driving...
Persistent link: https://www.econbiz.de/10011670851
To examine the drivers of innovation, this paper studies the global R&D effort to fight the deadliest diseases and presents four results. We find: (1) global pharmaceutical R&D activity - measured by clinical trials - typically follows the 'law of diminishing efforts': i.e. the elasticity of R&D...
Persistent link: https://www.econbiz.de/10012430944
A recent debate in the medical literature has arisen around the mortality effects of obesity. Whereas it has been argued that the obese die younger, the data that have become available do not immediately support this. This potentially undermines the hypothesis that modern life with its physical...
Persistent link: https://www.econbiz.de/10003832183
In this paper I examine the characteristics of adults who report on whether they have health care coverage and of people who say that they are unable to see a doctor over the preceding year because of the cost. I make use of a unique data set, the Behavioral Risk Factor Surveillance System, a...
Persistent link: https://www.econbiz.de/10003901166
"The excess female mortality in India and other South Asian countries is no longer contentious. Less known are the reasons for such excess female mortality in the country. In this study, we argue that intra-household gender-discrimination in receipt of medical attention can be one of the most...
Persistent link: https://www.econbiz.de/10003449480
This paper analyzes the effects of child adoption on the utilization of assisted reproductive technology (ART) in the US. Using state-level longitudinal data for 1999-2006, we show that ART use is responsive to changes in adoption markets. Controlling for state-specific fixed effects, the...
Persistent link: https://www.econbiz.de/10003940438
Persistent link: https://www.econbiz.de/10008904072